Pharmacists in Niskayuna, New York


13 Pharmacists found in Niskayuna
female pharmacist

Carmen Mojica, RPH, M.S.


Pharmacist
42 Macaulay Ln, Niskayuna, NY 12309
518-320-6861    

female pharmacist

Dr. Catherine Marie Festine, PHARMD


Pharmacist
2333 Nott St E, Niskayuna, NY 12309
518-243-4567    

female pharmacist

Catherine Thomas, PHARM.D.


Pharmacist
1334 Balltown Rd Ste 1, Niskayuna, NY 12309
518-374-7730    



male pharmacist

David Otto Lange, BS


Pharmacist
2205 Nott St, Niskayuna, NY 12309
518-374-3324     518-374-3325

female pharmacist

Deborah Spataro


Pharmacist
3333 Consaul Rd, Niskayuna, NY 12309
518-395-9798     518-346-4630

female pharmacist

Jeena Joseph


Pharmacist
43 Tamarack Ln, Niskayuna, NY 12309
518-925-2688    

male pharmacist

Dr. Jeffrey Scott Nissen, PHARM.D.


Pharmacist
4 Alice Wagner Way Apt 13, Niskayuna, NY 12309
732-995-0834    

male pharmacist

John A Carriola, RPH


Pharmacist
1805 Providence Ave, Niskayuna, NY 12309
518-381-9033     518-374-6985

female pharmacist

Julia Ann Horsch


Pharmacist
2333 Nott St E, Niskayuna, NY 12309
518-243-4568     518-243-4570

female pharmacist

Ms. Megan Ann Rogan, PHARMD


Pharmacist
2333 Nott St E, Niskayuna, NY 12309
518-243-4568    

male pharmacist

Paul Raymond Molesky Sr., RPH


Pharmacist
1334 Balltown Rd, Niskayuna, NY 12309
518-374-7730     518-374-6470

female pharmacist

Ms. Rabia R Sheikh, RPH


Pharmacist
1277 Ardmore Court, Niskayuna, NY 12309
518-370-2372    

female pharmacist

Sarah E Laplant, RPH


Pharmacist
1334 Balltown Rd, Niskayuna, NY 12309
518-374-7730    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.